[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-immunitybio-stock-soars-42-after-new-anktiva-approvals-heres-whats-driving-the-rally-FR":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":265,"suggestedPosts":343},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},93307,"L'action d'ImmunityBio s'envole de 42% après les nouvelles autorisations d'Anktiva. Voici ce qui motive le rallye","2026-02-19T21:30:00","2026-02-19T05:46:36","\u003Cp>Voici pourquoi l'action d'ImmunityBio a bondi de 42 %, alors que les nouvelles autorisations d'Anktiva et la croissance rapide du chiffre d'affaires ont alimenté une forte réévaluation de cette biotech à haut risque.\u003C\u002Fp>\n","\n\u003Ch2 class=\"wp-block-heading\" id=\"h-k-ey-stats-for-ibrx-stock\">\u003Cstrong>Principales statistiques\u003C\u002Fstrong> pour l'\u003Cstrong> action \u003Cstrong>IBRX\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Evolution du cours de l'action \u003Cstrong>IBRX\u003C\u002Fstrong>:\u003C\u002Fstrong> +41.86%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Cstrong>IBRX\u003C\u002Fstrong>\u003C\u002Fstrong> \u003Cstrong>Cours de l'action au 18 \u003Cstrong>février \u003C\u002Fstrong>:\u003C\u002Fstrong> $8.54\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Plus haut sur 52 semaines :\u003C\u002Fstrong> 8,68\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Cstrong>IBRX\u003C\u002Fstrong>\u003C\u002Fstrong> \u003Cstrong>Objectif de cours : \u003C\u002Fstrong> 11,80\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">En direct : Découvrez le potentiel de hausse de vos actions préférées en utilisant le nouveau modèle d'évaluation de TIKR (c'est gratuit).\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">&gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">Qu'est-ce qui s'est passé ?\u003C\u002Fh2>\n\n\n\n\u003Cp>ImmunityBio (\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">IBRX\u003C\u002Fa>\u003C\u002Fstrong>) a bondi de 40 % après qu'une vague de mises à jour réglementaires et cliniques ait mis en évidence le potentiel commercial de sa principale immunothérapie, Anktiva. \u003C\u002Fp>\n\n\n\n\u003Cp>Les régulateurs européens ont accordé une autorisation de mise sur le marché conditionnelle pour Anktiva en combinaison avec le BCG pour traiter certains patients atteints d'un cancer de la vessie non invasif et non musclé ne répondant pas au BCG, élargissant ainsi la portée du médicament au-delà des Etats-Unis.\u003C\u002Fp>\n\n\n\n\u003Cp>Reuters a également fait état de données de phase 2 actualisées pour le glioblastome et de nouveaux essais de phase 2 pour les programmes de thérapie cellulaire CAR-NK, renforçant ainsi l'étendue du portefeuille de produits de la société.\u003C\u002Fp>\n\n\n\n\u003Cp>Dans le même temps, l'entreprise a régulièrement annoncé des mesures d'expansion géographique, notamment la création d'une nouvelle filiale saoudienne pour stimuler la croissance au Moyen-Orient et en Afrique du Nord, que les investisseurs considèrent comme un important canal de croissance à long terme.\u003C\u002Fp>\n\n\n\n\u003Cp>Ces étapes viennent s'ajouter aux approbations antérieures qui ont contribué à faire d'ImmunityBio une biotech en phase de commercialisation. Aux États-Unis, Anktiva est déjà approuvé par la FDA, en association avec le BCG, pour les patients adultes atteints d'un cancer de la vessie non invasif sur le plan musculaire et ne répondant pas au BCG, avec carcinome in situ, avec ou sans tumeurs papillaires.\u003C\u002Fp>\n\n\n\n\u003Cp>Ces succès réglementaires expliquent pourquoi TIKR affiche un rendement total sur un an supérieur à 150 % et pourquoi le volume des transactions a bondi, avec un volume moyen sur trois mois de plus de 27 millions d'actions.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"1130\" height=\"610\" data-public-id=\"images\u002FIBRX-Street-Targets-1_93308da163\u002FIBRX-Street-Targets-1_93308da163.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1130,h_610,c_scale\u002Ff_webp,q_auto\u002Fv1771479246\u002Fimages\u002FIBRX-Street-Targets-1_93308da163\u002FIBRX-Street-Targets-1_93308da163.webp?_i=AA\" alt=\"\" class=\"wp-post-93307 wp-image-93308\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1771479246\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1771479246\u002Fimages\u002FIBRX-Street-Targets-1_93308da163\u002FIBRX-Street-Targets-1_93308da163.webp?_i=AA 1130w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_162,c_scale\u002Ff_webp,q_auto\u002Fv1771479246\u002Fimages\u002FIBRX-Street-Targets-1_93308da163\u002FIBRX-Street-Targets-1_93308da163.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_553,c_scale\u002Ff_webp,q_auto\u002Fv1771479246\u002Fimages\u002FIBRX-Street-Targets-1_93308da163\u002FIBRX-Street-Targets-1_93308da163.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_415,c_scale\u002Ff_webp,q_auto\u002Fv1771479246\u002Fimages\u002FIBRX-Street-Targets-1_93308da163\u002FIBRX-Street-Targets-1_93308da163.webp?_i=AA 768w\" sizes=\"auto, (max-width: 1130px) 100vw, 1130px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Objectifs de cours de l'action IBRX\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">(TIKR\u003C\u002Fa>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Voir les prévisions de croissance et les objectifs de prix des analystes pour l'action IBRX (C'est gratuit !) &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-the-market-is-telling-us-about-ibrx-stock\">Ce que le marché nous dit à propos de l'action IBRX\u003C\u002Fh2>\n\n\n\n\u003Cp>Même après le dernier pic, le prix de l'action d'ImmunityBio d'environ 9 $ se situe toujours en dessous de l'objectif moyen de 11,80 $ de la Bourse, avec des estimations individuelles d'analystes allant du milieu à un chiffre jusqu'à 24 $.\u003C\u002Fp>\n\n\n\n\u003Cp>L'action a également oscillé entre un plus bas de 52 semaines proche de 1,83 $ et un plus haut récent de 8,68 $, soulignant la rapidité avec laquelle le sentiment peut changer en réponse aux nouvelles cliniques et réglementaires.\u003C\u002Fp>\n\n\n\n\u003Cp>Les états financiers de TIKR mettent en évidence à la fois l'opportunité et le risque. Au cours des douze derniers mois, ImmunityBio a généré environ 82,6 millions de dollars de revenus, contre seulement 0,93 million de dollars trois ans plus tôt, ce qui représente une croissance extrêmement rapide à partir d'une petite base.\u003C\u002Fp>\n\n\n\n\u003Cp>Cependant, les pertes d'exploitation ont dépassé 260 millions de dollars au cours de la même période, les pertes nettes se sont élevées à plus de 340 millions de dollars et le flux de trésorerie disponible a été approximativement négatif de 325 millions de dollars, ce qui reflète des investissements substantiels dans les essais et les lancements.\u003C\u002Fp>\n\n\n\n\u003Cp>Le bilan fait état d'un actif total d'environ 519 millions de dollars, mais d'un passif total de plus de 1,0 milliard de dollars, dont plus de 800 millions de dollars de dettes à long terme et de contrats de location-acquisition, de sorte que l'entreprise reste tributaire du financement externe et de l'émission d'actions pour financer ses activités.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Estimez instantanément la juste valeur d'une entreprise (gratuit avec TIKR) &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-how-much-upside-does-ibrx-stock-have-from-here\">Quelle est l'ampleur de la hausse de l'action IBRX à partir de maintenant ?\u003C\u002Fh2>\n\n\n\n\u003Cp>Grâce au \u003Cstrong>nouveau modèle d'évaluation de\u003C\u002Fstrong> TIKR, vous pouvez estimer le prix potentiel d'une action en moins d'une minute.\u003C\u002Fp>\n\n\n\n\u003Cp>Tout ce qu'il faut, ce sont trois données simples :\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\n\u003Cli>\u003Cem>Croissance du chiffre d'affaires\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Marges d'exploitation\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Multiplicateur de prix de sortie\u003C\u002Fem>\u003C\u002Fli>\n\u003C\u002Fol>\n\n\n\n\u003Cp>Si vous n'êtes pas sûr de ce qu'il faut saisir, TIKR remplit automatiquement chaque entrée en utilisant les estimations consensuelles des analystes, ce qui vous donne un point de départ rapide et fiable.\u003C\u002Fp>\n\n\n\n\u003Cp>TIKR calcule ensuite le prix potentiel de l'action et le rendement total dans le cadre de \u003Cstrong>scénarios\u003C\u002Fstrong> \u003Cstrong>haussier, baissier et de base,\u003C\u002Fstrong> ce qui vous permet de voir rapidement si une action est \u003Cstrong>sous-évaluée ou surévaluée\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Découvrez la valeur réelle d'une action en moins de 60 secondes (gratuit avec TIKR) &gt;&gt;&gt;\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-looking-for-new-opportunities\">À la recherche de nouvelles opportunités ?\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Voyez quelles actions\u003Cstrong> \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">les investisseurs milliardaires achètent\u003C\u002Fa> \u003C\u002Fstrong>afin que vous puissiez suivre l'argent intelligent.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Analysez les actions en seulement 5 minutes\u003C\u002Fa>\u003C\u002Fstrong> grâce à la plateforme tout-en-un et facile à utiliser de TIKR.\u003C\u002Fli>\n\n\n\n\u003Cli>Plus vous renversez de pierres... plus vous découvrirez d'opportunités. \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Recherchez plus de 100 000 actions mondiales, les titres des principaux investisseurs mondiaux, et plus encore avec TIKR.\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Avis de non-responsabilité :\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Cem>Veuillez noter que les articles de TIKR ne sont pas destinés à servir de conseils financiers ou d'investissement de la part de TIKR ou de notre équipe de contenu, et qu'ils ne constituent pas non plus des recommandations d'achat ou de vente d'actions. Nous créons notre contenu en nous basant sur les données d'investissement de TIKR Terminal et sur les estimations des analystes. Notre analyse peut ne pas inclure des nouvelles récentes de l'entreprise ou des mises à jour importantes. TIKR n'a aucune position dans les actions mentionnées. Nous vous remercions de votre lecture et vous souhaitons de bons investissements !\u003C\u002Fem>\u003C\u002Fp>\n",694,"fr","\u002Fblog\u002Fimmunitybio-stock-soars-42-after-new-anktiva-approvals-heres-whats-driving-the-rally","immunitybio-stock-soars-42-after-new-anktiva-approvals-heres-whats-driving-the-rally","images\u002FIBRX-stock-2\u002FIBRX-stock-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771479866\u002Fimages\u002FIBRX-stock-2\u002FIBRX-stock-2.png?_i=AA",{"altText":237,"imageCredit":238},"ImmunityBio Stock Soars 42% After New Anktiva Approvals. Here’s What’s Driving the Rally","Изображения пользователя Be Easy via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Rexielyn Diaz","rexietikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Here’s why ImmunityBio stock surged 42% as new Anktiva approvals and rapid revenue growth fueled a sharp re‑rating of this high‑risk biotech.",{"title":237,"description":258,"twitterTitle":237,"twitterDescription":258,"author":240,"articlePublisher":260,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":261,"twitterData1":262,"ogTitle":237,"ogDescription":258,"ogUrl":232,"ogImage":235,"ogImageWidth":263,"ogImageHeight":264,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"TIKR.com","Temps de lecture estimé","5 minutes",1200,630,[266,281,296,311,326],{"id":255,"title":267,"date":268,"excerpt":269,"wordCount":270,"uri":271,"slug":272,"cloudinaryAssetId":273,"featuredImageOriginalUrl":274,"featuredImageMetadata":275,"author":276,"categories":278,"relatedPosts":280},"L'action d'Axcelis Technologies chute de 17 % après la publication des résultats. Voici ce que des prévisions plus souples pour 2026 signifient pour la demande d'équipement en puces électroniques","2026-02-19 21:00:00","Voici pourquoi l'action d'Axcelis a chuté de 17% après que les résultats positifs du quatrième trimestre aient été éclipsés par des prévisions médiocres pour 2026 et par l'incertitude liée à la fusion.",658,"\u002Fblog\u002Faxcelis-technologies-stock-drops-17-after-earnings-heres-what-soft-2026-guidance-signals-for-chip%e2%80%91equipment-demand","axcelis-technologies-stock-drops-17-after-earnings-heres-what-soft-2026-guidance-signals-for-chip%e2%80%91equipment-demand","images\u002FACLS-stock\u002FACLS-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771478599\u002Fimages\u002FACLS-stock\u002FACLS-stock.png?_i=AA",{"altText":267},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":277},[],[279],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":282,"date":283,"excerpt":284,"wordCount":285,"uri":286,"slug":287,"cloudinaryAssetId":288,"featuredImageOriginalUrl":289,"featuredImageMetadata":290,"author":291,"categories":293,"relatedPosts":295},"L'action Madison Square Garden Sports a augmenté de 35 % au cours des trois derniers mois. Voici ce que les bons résultats du 2e trimestre laissent présager pour 2026","2026-02-19 20:30:00","Voici pourquoi l'action MSGS a atteint de nouveaux sommets cette semaine grâce à des résultats solides au deuxième trimestre et à un optimisme croissant quant à une éventuelle scission entre les Knicks et les Rangers.",731,"\u002Fblog\u002Fmadison-square-garden-sports-stock-is-up-35-in-the-past-3-months-heres-what-strong-q2-results-signal-for-2026","madison-square-garden-sports-stock-is-up-35-in-the-past-3-months-heres-what-strong-q2-results-signal-for-2026","images\u002FMSGS-stock\u002FMSGS-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771477776\u002Fimages\u002FMSGS-stock\u002FMSGS-stock.png?_i=AA",{"altText":282},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":292},[],[294],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":297,"date":298,"excerpt":299,"wordCount":300,"uri":301,"slug":302,"cloudinaryAssetId":303,"featuredImageOriginalUrl":304,"featuredImageMetadata":305,"author":306,"categories":308,"relatedPosts":310},"L'action VNET perd 9 % cette semaine. Voici ce qui a déclenché la chute","2026-02-19 20:20:00","Voici pourquoi l'action VNET a chuté de 9 % après que les investisseurs ont réagi aux mises à jour liées à son accord d'investissement et à ses obligations convertibles.",649,"\u002Fblog\u002Fvnet-stock-slips-9-this-week-heres-what-triggered-the-selloff","vnet-stock-slips-9-this-week-heres-what-triggered-the-selloff","images\u002FVNET-stock\u002FVNET-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771501346\u002Fimages\u002FVNET-stock\u002FVNET-stock.png?_i=AA",{"altText":297},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":307},[],[309],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":312,"date":313,"excerpt":314,"wordCount":315,"uri":316,"slug":317,"cloudinaryAssetId":318,"featuredImageOriginalUrl":319,"featuredImageMetadata":320,"author":321,"categories":323,"relatedPosts":325},"L'action DINO a chuté de 11 % en raison de problèmes de gouvernance : Ce que le départ du PDG signifie pour les investisseurs","2026-02-19 20:10:00","Voici pourquoi l'action DINO a chuté de 11 %, les investisseurs s'étant concentrés sur le congé du PDG et sur l'examen du comité d'audit, malgré de solides bénéfices.",605,"\u002Fblog\u002Fdino-stock-fell-11-on-governance-concerns-what-the-ceo-leave-means-for-investors","dino-stock-fell-11-on-governance-concerns-what-the-ceo-leave-means-for-investors","images\u002FDINO-stock\u002FDINO-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771500528\u002Fimages\u002FDINO-stock\u002FDINO-stock.png?_i=AA",{"altText":312},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":322},[],[324],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":327,"date":328,"excerpt":329,"wordCount":330,"uri":331,"slug":332,"cloudinaryAssetId":333,"featuredImageOriginalUrl":334,"featuredImageMetadata":335,"author":336,"categories":340,"relatedPosts":342},"Valaris est en hausse de 70 % au cours des 30 derniers jours. Voici ce que l'action pourrait devenir en 2026","2026-02-19 20:05:00","L'action Valaris a augmenté de 70 % au cours des 30 derniers jours après la conclusion d'un accord de 5,8 milliards de dollars avec Transocean. Voici pourquoi la consolidation de l'offshore, un carnet de commandes de 10 milliards de dollars et l'amélioration du pouvoir de fixation des prix pourraient soutenir la hausse jusqu'en 2026.",660,"\u002Fblog\u002Fvalaris-is-up-70-in-the-last-30-days-heres-where-the-stock-could-head-into-2026","valaris-is-up-70-in-the-last-30-days-heres-where-the-stock-could-head-into-2026","images\u002F@Igors-Aleksejevs-from-Getty-Images-via-Canva\u002F@Igors-Aleksejevs-from-Getty-Images-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771530800\u002Fimages\u002F@Igors-Aleksejevs-from-Getty-Images-via-Canva\u002F@Igors-Aleksejevs-from-Getty-Images-via-Canva.png?_i=AA",{"altText":327},{"name":337,"slug":338,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":339},"Nikko Henson","nikkotikr",[],[341],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[344,364,379,394,409,424,444,459,473,488],{"id":255,"title":345,"date":346,"excerpt":347,"wordCount":348,"uri":349,"slug":350,"cloudinaryAssetId":351,"featuredImageOriginalUrl":352,"featuredImageMetadata":353,"author":354,"categories":358,"relatedPosts":363},"Merck bat les bénéfices du T4 mais manque ses prévisions pour 2026. Voici ce que les investisseurs doivent savoir","2026-02-19 19:23:00","Wall Street a passé des mois à traiter Merck comme une société à médicament unique confrontée à la falaise de KEYTRUDA. Trois approbations de la FDA, un accord avec la Mayo Clinic AI et un objectif de 179 dollars pour le modèle montrent que cette histoire est dangereusement dépassée.\n",774,"\u002Fblog\u002Fmerck-beat-q4-earnings-but-missed-2026-guidance-heres-what-investors-need-to-know","merck-beat-q4-earnings-but-missed-2026-guidance-heres-what-investors-need-to-know","images\u002FFEATURED-IMAGE-MAKER-258\u002FFEATURED-IMAGE-MAKER-258","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771515753\u002Fimages\u002FFEATURED-IMAGE-MAKER-258\u002FFEATURED-IMAGE-MAKER-258.png?_i=AA",{"altText":345},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":357},"Gian Estrada","giantikr",[],[359],{"name":360,"slug":361,"uri":362,"description":243,"postsCount":255},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":365,"date":366,"excerpt":367,"wordCount":368,"uri":369,"slug":370,"cloudinaryAssetId":371,"featuredImageOriginalUrl":372,"featuredImageMetadata":373,"author":374,"categories":376,"relatedPosts":378},"L'action McKesson a progressé de 58 % au cours de la dernière année : Voici pourquoi les analystes signalent une surévaluation potentielle","2026-02-19 16:00:00","Le 4 février, l'action McKesson a relevé ses prévisions de BPA ajusté pour l'exercice 2026 à 38,80 $ - 39,20 $ après que le bénéfice d'exploitation du segment oncologie a bondi de 57 %, mais trois initiés de haut niveau ont cédé des actions dans les 10 jours suivant la publication des résultats, créant ainsi une tension que le rendement annualisé de 5,7 % pourrait ne pas résoudre.",2137,"\u002Fblog\u002Fmckesson-stock-has-rallied-58-over-the-past-year-heres-why-analysts-flag-a-potential-overvaluation","mckesson-stock-has-rallied-58-over-the-past-year-heres-why-analysts-flag-a-potential-overvaluation","images\u002FFEATURED-IMAGE-MAKER-256\u002FFEATURED-IMAGE-MAKER-256","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771506399\u002Fimages\u002FFEATURED-IMAGE-MAKER-256\u002FFEATURED-IMAGE-MAKER-256.png?_i=AA",{"altText":365},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":375},[],[377],{"name":360,"slug":361,"uri":362,"description":243,"postsCount":255},[],{"id":255,"title":380,"date":381,"excerpt":382,"wordCount":383,"uri":384,"slug":385,"cloudinaryAssetId":386,"featuredImageOriginalUrl":387,"featuredImageMetadata":388,"author":389,"categories":391,"relatedPosts":393},"L'action DaVita est en hausse de 35 % depuis février. Voici où les actions pourraient aller en 2026","2026-02-19 14:20:00","Un bond de 33 % des prévisions de BPA, un pari d'expansion de 200 millions de dollars et une étape de rentabilité attendue depuis longtemps. Voici pourquoi la hausse de 35 % de DaVita en février n'est peut-être qu'un début.",713,"\u002Fblog\u002Fdavita-stock-is-up-35-since-february-heres-where-shares-could-go-in-2026","davita-stock-is-up-35-since-february-heres-where-shares-could-go-in-2026","images\u002FFEATURED-IMAGE-MAKER-257\u002FFEATURED-IMAGE-MAKER-257","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771509556\u002Fimages\u002FFEATURED-IMAGE-MAKER-257\u002FFEATURED-IMAGE-MAKER-257.png?_i=AA",{"altText":380},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":390},[],[392],{"name":360,"slug":361,"uri":362,"description":243,"postsCount":255},[],{"id":255,"title":395,"date":396,"excerpt":397,"wordCount":398,"uri":399,"slug":400,"cloudinaryAssetId":401,"featuredImageOriginalUrl":402,"featuredImageMetadata":403,"author":404,"categories":406,"relatedPosts":408},"L'action IDEXX a progressé de 40 % au cours de l'année écoulée : Un nouveau PDG peut-il maintenir l'élan ?","2026-02-19 13:17:00","L'annonce de la succession du PDG d'IDEXX Laboratories en janvier, associée aux prévisions de février de la direction qui intègrent une baisse de 2 % des visites en clinique aux États-Unis, pourrait offrir une hausse totale de 59 % jusqu'en décembre 2030 si la nouvelle direction maintient la trajectoire des revenus récurrents de CAG Diagnostics qui a entraîné une appréciation de l'action de 64 % en 2025.",2079,"\u002Fblog\u002Fidexx-stock-has-rallied-40-over-the-past-year-can-a-new-ceo-keep-the-momentum-going","idexx-stock-has-rallied-40-over-the-past-year-can-a-new-ceo-keep-the-momentum-going","images\u002FFEATURED-IMAGE-MAKER-255\u002FFEATURED-IMAGE-MAKER-255","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771497436\u002Fimages\u002FFEATURED-IMAGE-MAKER-255\u002FFEATURED-IMAGE-MAKER-255.png?_i=AA",{"altText":395},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":405},[],[407],{"name":360,"slug":361,"uri":362,"description":243,"postsCount":255},[],{"id":255,"title":410,"date":411,"excerpt":412,"wordCount":413,"uri":414,"slug":415,"cloudinaryAssetId":416,"featuredImageOriginalUrl":417,"featuredImageMetadata":418,"author":419,"categories":421,"relatedPosts":423},"L'action IQVIA a déjà baissé de 25 % cette année : Voici ce que disent les analystes","2026-02-19 13:00:00","L'action IQVIA a chuté de 8 % le 5 février, après avoir annoncé un bénéfice par action ajusté pour 2026 de 12,55 à 12,85 dollars, inférieur au consensus de 12,95 dollars, même si le carnet de commandes de R&DS a atteint un record de 32,7 milliards de dollars, ce qui laisse une marge totale de 67 % par rapport à l'objectif intermédiaire que le ratio cours\u002Fbénéfice prévisionnel actuel de 13x ne permet peut-être pas encore d'évaluer.",2113,"\u002Fblog\u002Fiqvia-stock-dropped-8-on-weak-eps-guidance-heres-what-the-numbers-say-in-2026","iqvia-stock-dropped-8-on-weak-eps-guidance-heres-what-the-numbers-say-in-2026","images\u002FFEATURED-IMAGE-MAKER-254\u002FFEATURED-IMAGE-MAKER-254","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1771471536\u002Fimages\u002FFEATURED-IMAGE-MAKER-254\u002FFEATURED-IMAGE-MAKER-254.png?_i=AA",{"altText":410},{"name":355,"slug":356,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":420},[],[422],{"name":360,"slug":361,"uri":362,"description":243,"postsCount":255},[],{"id":255,"title":425,"date":426,"excerpt":427,"wordCount":428,"uri":429,"slug":430,"cloudinaryAssetId":431,"featuredImageOriginalUrl":432,"featuredImageMetadata":433,"author":434,"categories":438,"relatedPosts":443},"L'action Vertex Pharmaceuticals bondit de 7 % suite à la révision à la hausse d'Oppenheimer : voici où l'action pourrait aller en 2026","2026-02-17 20:45:00","Vertex Pharmaceuticals a atteint un sommet de 5 semaines après que les analystes d'Oppenheimer ont relevé le prix de l'action, citant le potentiel massif de son pipeline de maladies rénales.",760,"\u002Fblog\u002Fvertex-pharmaceuticals-stock-jumps-7-following-oppenheimer-upgrade-heres-where-the-stock-could-go-in-2026","vertex-pharmaceuticals-stock-jumps-7-following-oppenheimer-upgrade-heres-where-the-stock-could-go-in-2026","images\u002F2-7_92970b13a4\u002F2-7_92970b13a4","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771306128\u002Fimages\u002F2-7_92970b13a4\u002F2-7_92970b13a4.png?_i=AA",{"altText":425},{"name":435,"slug":436,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":437},"Wiltone Asuncion","wiltonetikr",[],[439],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":445,"date":446,"excerpt":447,"wordCount":448,"uri":449,"slug":450,"cloudinaryAssetId":451,"featuredImageOriginalUrl":452,"featuredImageMetadata":453,"author":454,"categories":456,"relatedPosts":458},"L'action Newmont est en hausse de 7 % dans le cadre d'un rallye historique de l'or. Voici où l'action pourrait se diriger en 2026","2026-02-17 20:15:00","Newmont Corporation a bondi de 7 %, les prix de l'or ayant battu des records, dépassant les 5 000 dollars l'once. ",742,"\u002Fblog\u002Fnewmont-stock-is-up-7-amid-historic-gold-rally-heres-where-the-stock-could-be-headed-in-2026","newmont-stock-is-up-7-amid-historic-gold-rally-heres-where-the-stock-could-be-headed-in-2026","images\u002F4-7_92972c9703\u002F4-7_92972c9703","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771306161\u002Fimages\u002F4-7_92972c9703\u002F4-7_92972c9703.png?_i=AA",{"altText":445},{"name":435,"slug":436,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":455},[],[457],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},[],{"id":255,"title":460,"date":446,"excerpt":461,"wordCount":462,"uri":463,"slug":464,"cloudinaryAssetId":465,"featuredImageOriginalUrl":466,"featuredImageMetadata":467,"author":468,"categories":470,"relatedPosts":472},"L'action d'Airbnb s'inscrit dans le cadre d'un boom des voyages : pourquoi la demande estivale record justifie un objectif de 265 $.","Les actions d'Airbnb ont grimpé après que Deutsche Bank a émis une note \"Acheter\", citant une ré-accélération de la demande de voyages. ",768,"\u002Fblog\u002Fairbnb-stock-is-pricing-in-a-major-travel-boom-why-record-summer-demand-supports-a-265-target","airbnb-stock-is-pricing-in-a-major-travel-boom-why-record-summer-demand-supports-a-265-target","images\u002F3-7_92971a891a\u002F3-7_92971a891a","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771306145\u002Fimages\u002F3-7_92971a891a\u002F3-7_92971a891a.png?_i=AA",{"altText":460},{"name":435,"slug":436,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":469},[],[471],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},[],{"id":255,"title":474,"date":475,"excerpt":476,"wordCount":477,"uri":478,"slug":479,"cloudinaryAssetId":480,"featuredImageOriginalUrl":481,"featuredImageMetadata":482,"author":483,"categories":485,"relatedPosts":487},"L'action NRG Energy bondit de 7 % après une hausse massive des prévisions. Voici l'ampleur de la hausse de l'action en 2026","2026-02-17 19:45:00","Les actions de NRG Energy ont bondi de 7 % après que la direction a augmenté ses prévisions pour 2026 de près de 35 %, citant la clôture de l'acquisition de LS Power. ",778,"\u002Fblog\u002Fnrg-energy-stock-jumps-7-after-massive-guidance-hike-heres-how-much-upside-the-stock-could-have-in-2026","nrg-energy-stock-jumps-7-after-massive-guidance-hike-heres-how-much-upside-the-stock-could-have-in-2026","images\u002F5-7_92974a34a8\u002F5-7_92974a34a8","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771306179\u002Fimages\u002F5-7_92974a34a8\u002F5-7_92974a34a8.png?_i=AA",{"altText":474},{"name":435,"slug":436,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":484},[],[486],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},[],{"id":255,"title":489,"date":490,"excerpt":491,"wordCount":492,"uri":493,"slug":494,"cloudinaryAssetId":495,"featuredImageOriginalUrl":496,"featuredImageMetadata":497,"author":498,"categories":500,"relatedPosts":502},"L'action de Trupanion est en baisse de 13 % après les résultats du quatrième trimestre : Les analystes prévoient-ils un rebond à 70 $ en 2026 ?","2026-02-17 19:30:00","L'action de Trupanion s'est effondrée après que l'assureur pour animaux de compagnie a annoncé des résultats insuffisants en raison d'une hausse des coûts d'acquisition des clients. ",809,"\u002Fblog\u002Ftrupanion-stock-is-down-13-following-q4-results-do-analysts-see-a-rebound-to-70-in-2026","trupanion-stock-is-down-13-following-q4-results-do-analysts-see-a-rebound-to-70-in-2026","images\u002F11-7\u002F11-7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1771306277\u002Fimages\u002F11-7\u002F11-7.png?_i=AA",{"altText":489},{"name":435,"slug":436,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":499},[],[501],{"name":440,"slug":441,"uri":442,"description":243,"postsCount":255},[]]